US2005095685A1PendingUtilityA1
Anti-hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin
Est. expiryJun 27, 2011(expired)· nominal 20-yr term from priority
C07K 14/815C07K 16/38Y10S530/855
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of producing an immunogen comprising polymerizing a hirudin and/or a hirudin-like protein is provided. A method of producing an antibody specific for a hirudin or a hirudin-like protein is also provided.
Claims
exact text as granted — not AI-modified1 . A method of producing an immunogen, which method comprises polymerising a hirudin and/or a hirudin-like protein.
2 . A method according to claim 1 wherein the hirudin and/or the hirudin-like protein are/is polymerized with glutaraldehyde.
3 . A method according to claim 1 or 2 wherein the hirudin is HV1 (SEQ ID NO: 1), HV2 (SEQ ID NO: 2), HV3 (SEQ ID NO: 3), P1 (SEQ ID NO: 4) or P2 (SEQ ID NO: 5).
4 . A method according to claim 1 or 2 wherein the hirudin-like protein is a derivative of HV1 (SEQ ID NO: 1), HV2 (SEQ ID NO: 2), HV3 (SEQ ID NO: 3), P1 (SEQ ID NO: 4) or P2 (SEQ ID NO: 5) by way of amino acid substitution, deletion, insertion, extension, functionalisation or chemical modification, said derivative having anti-thrombin activity.
5 . An immunogen comprising a polymerised hirudin and/or hirudin-like protein.
6 . An immunogen according to claim 5 wherein the hirudin is HV1 (SEQ ID NO: 1), HV2 (SEQ ID NO: 2), HV3 (SEQ ID NO: 3), P1 (SEQ ID NO: 4) or P2 (SEQ ID NO: 5).
7 . An immunogen according to claim 5 wherein the hirudin-like protein is a derivative of HV1 (SEQ ID NO: 1), HV2 (SEQ ID NO: 2), HV3 (SEQ ID NO: 3), P1 (SEQ ID NO: 4) or P2 (SEQ ID NO: 5) by way of amino acid substitution, deletion, insertion, extension, functionalisation or chemical modification, said derivative having anti-thrombin activity.
8 . An immunogen according to claim 5 , 6 or 7 obtainable by polymerising the hirudin and/or the hirudin-like protein with glutaraldehyde.
9 . A method of producing an antibody capable of binding to a hirudin or a hirudin-like protein, said method comprising raising antibody against an immunogen as claimed in claims 5 to 8 .
10 . A method according to claim 9 , wherein the said antibody is a polyclonal antibody.
11 . A method according to claim 9 , wherein the said antibody is a monoclonal antibody.
12 . A method for the quantitative determination, purification or identification of a hirudin or hirudin-like protein, said method comprising raising antibody against an immunogen as claimed in claims 5 to 8 , and using the antibody thereby obtained in said quantitative determination, purification or identification.Join the waitlist — get patent alerts
Track US2005095685A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.